Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

August 01, 2017; Volume 14,Issue 3

Guideline

  • You have access
    2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma
    Ming Gao, Minghua Ge, Qinghai Ji, Ruochuan Cheng, Hankui Lu, Haixia Guan, Li Gao, Zhuming Guo, Tao Huang, Xiaoming Huang, Xiaoming Li, Yansong Lin, Qinjiang Liu, Xin Ni, Yi Pan, Jianwu Qin, Zhongyan Shan, Hui Sun, Xudong Wang, Zhengang Xu, Yang Yu, Daiwei Zhao, Naisong Zhang, Sheng Zhang, Ying Zheng, Jingqiang Zhu, Dapeng Li, Xiangqian Zheng and Chinese Association of Thyroid Oncology, (CATO), Chinese Anti-Cancer Association
    Cancer Biology & Medicine August 2017, 14 (3) 203-211; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0051

Review

  • You have access
    Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
    Meng Zhang, Ergang Liu, Yanna Cui and Yongzhuo Huang
    Cancer Biology & Medicine August 2017, 14 (3) 212-227; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0054
  • You have access
    Recent progress on nanoparticle-based drug delivery systems for cancer therapy
    Yanru Xin, Mingming Yin, Liyuan Zhao, Fanling Meng and Liang Luo
    Cancer Biology & Medicine August 2017, 14 (3) 228-241; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0052
  • You have access
    Natural and artificial small RNAs: a promising avenue of nucleic acid therapeutics for cancer
    Sunny Yadav, Mamta Shekhawat, Devashree Jahagirdar and Nilesh Kumar Sharma
    Cancer Biology & Medicine August 2017, 14 (3) 242-253; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0038
  • You have access
    Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode
    Spiros A. Vlahopoulos
    Cancer Biology & Medicine August 2017, 14 (3) 254-270; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0029
  • You have access
    Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer
    Wei Chen, Xiaofeng Li, Lei Zhu, Jianjing Liu, Wengui Xu and Ping Wang
    Cancer Biology & Medicine August 2017, 14 (3) 271-280; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0044
  • You have access
    Survival after pulmonary metastasectomy in colorectal cancer patients: does a history of resected liver metastases worsen the prognosis? A literature review
    Jon Zabaleta, Borja Aguinagalde, Iker Lopez, Arantza Fernandez-Monge, Jose M. Izquierdo and Jose I. Emparanza
    Cancer Biology & Medicine August 2017, 14 (3) 281-286; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0073

Original Article

  • You have access
    BRAF mutation in colorectal carcinomas with signet ring cell component
    Serap Yalcin and Onder Onguru
    Cancer Biology & Medicine August 2017, 14 (3) 287-292; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0053
  • You have access
    Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation
    Avgi Tsolou, Maria Liousia, Dimitra Kalamida, Stamatia Pouliliou, Alexandra Giatromanolaki and Michael Koukourakis
    Cancer Biology & Medicine August 2017, 14 (3) 293-302; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0049
  • You have access
    BsmI (rs1544410) and FokI (rs2228570) vitamin D receptor polymorphisms, smoking, and body mass index as risk factors of cutaneous malignant melanoma in northeast Italy
    Sabina Cauci, Vincenzo Maione, Cinzia Buligan, Martina Linussio, Diego Serraino and Giuseppe Stinco
    Cancer Biology & Medicine August 2017, 14 (3) 302-318; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0064
  • You have access
    Expression levels of β-catenin and galectin-3 in meningioma and their effect on brain invasion and recurrence: a tissue microarray study
    Rehab Allah Ahmed, Abdelhadi M Shebl and Hany Onsy Habashy
    Cancer Biology & Medicine August 2017, 14 (3) 319-326; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0024
  • You have access
    Potential predictive factors for pathologic complete response after the neoadjuvant treatment of rectal adenocarcinoma: a single center experience
    Feryel Letaief, Meher Nasri, Mouna Ayadi, Khedija Meddeb, Amina Mokrani, Yosra Yahyaoui, Nesrine Chraiet, Henda Raies and Amel Mezlini
    Cancer Biology & Medicine August 2017, 14 (3) 327-334; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0037
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 14 (3)
Cancer Biology & Medicine
Vol. 14, Issue 3
1 Aug 2017
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Guideline
  • Review
  • Original Article

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire